Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Debt / NOTE 2.250% 9/0
-
Market price (% of par)
-
140.6%
-
Total 13F principal
-
$286,365,000
-
Principal change
-
+$285,268,000
-
Total reported market value
-
$405,529,327
-
Number of holders
-
24
-
Value change
-
+$403,973,581
-
Number of buys
-
23
Institutional Holders of ANI PHARMACEUTICALS INC - NOTE 2.250% 9/0 as of Q3 2025
As of 30 Sep 2025,
ANI PHARMACEUTICALS INC - NOTE 2.250% 9/0 was held by
24 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$286,365,000
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, CAMDEN ASSET MANAGEMENT L P /CA, BlackRock, Inc., HBK INVESTMENTS L P, Empyrean Capital Partners, LP, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, ABSOLUTE INVESTMENT ADVISERS, LLC, JPMORGAN CHASE & CO, and LAZARD ASSET MANAGEMENT LLC.
This page lists
24
institutional bondholders reporting positions
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.